ZTS · Zoetis Inc. · Earnings Call Transcripts & Audio
Market Cap
$31.33B
Shares
413.22M
Zoetis Inc. Earnings Call Transcripts
Quarterly earnings calls for Zoetis Inc. (ZTS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲0.6%
$2.00B
$529.00M
'22 Q3
22-11-03
▲3.7%
$2.04B
$461.00M
'22 Q4
23-02-14
▲0.7%
$2.00B
$552.00M
'23 Q1
23-05-04
▲6.2%
$2.18B
$671.00M
'23 Q2
23-08-08
▲7.4%
$2.15B
$596.00M
'23 Q3
23-11-02
▲8.5%
$2.21B
$525.00M
'23 Q4
24-02-13
▲9.5%
$2.19B
$599.00M
'24 Q1
24-05-02
▲8.3%
$2.36B
$624.00M
'24 Q2
24-08-06
▲11%
$2.39B
$682.00M
'24 Q3
24-11-04
▲4.7%
$2.32B
$581.00M
'24 Q4
25-02-13
▲0.4%
$2.20B
$602.00M
'25 Q1
25-05-06
▲4.8%
$2.47B
$726.00M
'25 Q2
25-08-05
▲0.5%
$2.40B
$721.00M
'25 Q3
25-12-02
▲3.4%
$2.40B
$624.00M
'25 Q4
26-02-12
▲2.9%
$2.26B
$601.00M
'26 Q1
26-05-07
LATEST
▼0.2%
$2.47B
$691.00M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Zoetis Inc. (ZTS) Q2 2026 Earnings Call Transcript
Revenue
$2.47B
▼ 0.2% YoY Diluted EPS
$1.65
▲ 1.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
Zoetis Inc. (ZTS) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-28
Zoetis Inc. (ZTS) May 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Zoetis Inc. (ZTS) Q1 2026 Earnings Call Transcript
Cautious tone
Competitive intensity
Companion animal pressure
OA Pain / Librela
Revenue
$2.26B
▲ 2.9% YoY Diluted EPS
$1.42
▲ 6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Zoetis Inc. (ZTS) March 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-12
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Positive tone
Livestock and international growth
Simparica / Trio franchise
2026 financial guidance
Revenue
$2.40B*
▲ 3.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-12-02
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Positive tone
OA pain franchise (Librela/Solensia/Lenivia/Portela)
Innovation pipeline and approvals
Parasiticides franchise (Simparica/Trio)
Revenue
$2.40B
▲ 0.5% YoY Diluted EPS
$1.63
▲ 8.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript
Confident tone
International and geographic growth
Companion Animal franchise momentum
Librela / OA Pain adoption challenges
Revenue
$2.47B
▲ 4.8% YoY Diluted EPS
$1.63
▲ 19% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript
Confident tone
Companion animal growth (Simparica, dermatology, OA pain)
Librela / OA pain adoption ramp
Tariffs and pharmaceutical policy (Section 232)
Revenue
$2.20B
▲ 0.4% YoY Diluted EPS
$1.34
▲ 2.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Confident tone
Companion animal growth and key franchises
Osteoarthritis pain franchise (Librela/Solensia)
2025 financial guidance and outlook
Revenue
$2.32B*
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
Confident tone
Librela/Solensia (OA pain franchise)
Dermatology franchise (Apoquel/Cytopoint)
Simparica Trio (parasiticides)
Revenue
$2.39B
▲ 11% YoY Diluted EPS
$1.50
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Zoetis Inc. (ZTS) Q2 2024 Earnings Call Transcript
Confident tone
Dermatology franchise (Apoquel/Cytopoint)
Companion animal innovation (Librela/Solensia)
Livestock portfolio
Revenue
$2.36B
▲ 8.3% YoY Diluted EPS
$1.37
▼ 5.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Zoetis Inc. (ZTS) Q1 2024 Earnings Call Transcript
Confident tone
Companion animal / OA pain franchise (Librela, Solensia)
Librela safety / FDA and vet engagement
Parasiticides (Simparica, Simparica Trio)
Revenue
$2.19B
▲ 9.5% YoY Diluted EPS
$1.31
▲ 10.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Zoetis Inc. (ZTS) Q4 2023 Earnings Call Transcript
Confident tone
Librela / Solensia (OA pain monoclonal antibodies)
2024 financial guidance and outlook
Companion animal portfolio
Revenue
$2.21B*
▲ 8.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Zoetis Inc. (ZTS) Q3 2023 Earnings Call Transcript
Revenue
$2.15B
▲ 7.4% YoY Diluted EPS
$1.29
▲ 14.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Zoetis Inc. (ZTS) Q2 2023 Earnings Call Transcript
Revenue
$2.18B
▲ 6.2% YoY Diluted EPS
$1.45
▲ 29.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Zoetis Inc. (ZTS) Q1 2023 Earnings Call Transcript
Revenue
$2.00B
▲ 0.7% YoY Diluted EPS
$1.19
▼ 5.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Zoetis Inc. (ZTS) Q4 2022 Earnings Call Transcript
Revenue
$2.04B*
▲ 3.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Zoetis Inc. (ZTS) Q3 2022 Earnings Call Transcript
Revenue
$2.00B
▲ 0.6% YoY Diluted EPS
$1.13
▼ 2.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Zoetis Inc. (ZTS) Q2 2022 Earnings Call Transcript
Revenue
$2.05B
▲ 5.3% YoY Diluted EPS
$1.12
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Zoetis Inc. (ZTS) Q1 2022 Earnings Call Transcript
Revenue
$1.99B
▲ 6.1% YoY Diluted EPS
$1.26
▲ 7.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Zoetis Inc. (ZTS) Q4 2021 Earnings Call Transcript
Revenue
$1.97B*
▲ 8.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Zoetis Inc. (ZTS) Q3 2021 Earnings Call Transcript
Revenue
$1.99B
▲ 11.4% YoY Diluted EPS
$1.16
▲ 16% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Zoetis Inc. (ZTS) Q2 2021 Earnings Call Transcript
Revenue
$1.95B
▲ 25.8% YoY Diluted EPS
$1.07
▲ 35.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Zoetis Inc. (ZTS) Q1 2021 Earnings Call Transcript
Revenue
$1.87B
▲ 22% YoY Diluted EPS
$1.17
▲ 33% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
Zoetis Inc. (ZTS) Q4 2020 Earnings Call Transcript
Revenue
$1.81B*
▲ 7.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Zoetis Inc. (ZTS) Q3 2020 Earnings Call Transcript
Revenue
$1.79B
▲ 12.8% YoY Diluted EPS
$1.00
▲ 11.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Revenue
$1.55B
▲ 0.1% YoY Diluted EPS
$0.79
▲ 2.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Zoetis Inc. (ZTS) Q1 2020 Earnings Call Transcript
Revenue
$1.53B
▲ 5.4% YoY Diluted EPS
$0.88
▲ 35.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Zoetis Inc. (ZTS) Q4 2019 Earnings Call
Revenue
$1.67B
▲ 7% YoY Diluted EPS
$0.80
▲ 12.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls
Key facts
CIK
1555280
CUSIP
98978V103
13F (30d)
578 filings
563 filers
Visit website
Investor relations